July 20, 2023
NIPT analyzes the baby's DNA from a blood sample taken from the mother's arm to detect chromosomal disorders, with results available in 3 to 5 working days.
May 30, 2023
Genoks was founded in 2008 by lawyer Özden BOSTAN. It is a pioneer in Turkey in NIPT performed with Next-Generation Sequencing (NGS) technology and operates as a Genetic Diseases Evaluation Center.
May 30, 2023
Patented by Genoks Genetic Diseases Evaluation Center, RapidNIPT is reported within 3 working days. In some cases this period can extend up to 5 working days.
May 30, 2023
The baby's sex is usually determined between weeks 16 and 20 of pregnancy through ultrasound, with blood tests and genetic tests offering earlier insights.
February 3, 2023
RapidNIPT screens for over 90 genetic conditions, including Down syndrome, using cfDNA analysis. It is a non-invasive NIPT test that poses no risk to the mother or the baby and offers a high level of accuracy.
February 3, 2023
Onkogenoks is the brand of Genoks Genetic Diseases Evaluation Center focused on cancer genetics and precision oncology, providing hereditary cancer panels and tumor profiling.
February 3, 2023
A carrier screening test is a genetic examination designed to identify individuals who carry the genetic mutation of an inherited disease.